等待開盤 08-05 09:30:00 美东时间
+0.210
+1.54%
摩根大通近日发布一份研究报告,房地产投资信托基金(REITs)在2025年的回报率预计约为10%,但不同物业类型的增长潜力与机会将呈现分化。
06-12 14:41
Real estate investment trusts are expected to see returns of about 10% in 2025, but growth and opportunities will vary among the property types, according to a research note from J.P. Morgan. "We beli...
06-12 02:19
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1136940401951563776.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• RBC Capital:维持Perspective Therapeutics(CATX)"跑赢大市"评级,目标价从15美元升至16美元</p> <p>• Canaccord Genuity:维持Taysha Gene Th
06-04 08:35
Truist Securities analyst Anthony Hau maintains Peakstone Realty Tr (NYSE:PKST) with a Hold and raises the price target from $15 to $16.
06-03 22:32
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1129333511617925121.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 蒙特利尔银行:维持Disc Medicine(IRON)"跑赢大市"评级,目标价从112美元升至120美元</p> <p>• 巴克莱:维持Karyopharm Therapeutics(KPTI)"超配"评级,目标价从5美
05-14 08:48
UBS analyst Michael Goldsmith maintains Peakstone Realty Tr (NYSE:PKST) with a Buy and raises the price target from $14 to $15.
05-13 23:45
PeakStone Realty Trust shares are trading lower following Q1 reported financial...
05-09 21:09
Companies Reporting Before The Bell • Sempra (NYSE:SRE) is likely to report qua...
05-08 16:33
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1111211417521721345.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.:维持Enlivex Therapeutics(ENLV)"买入"评级,目标价从6美元升至7美元</p> <p>• Maxim Group:上调Nexalin Technolo
03-25 09:37
Wall Street analysts continue to prefer value stocks during market corrections and periods of volatility. “Value stocks excel in bear markets, preserving capital and potentially outperforming over lon...
03-24 23:48